| For: | Qin YC, Yan X, Yuan XL, Yu WW, Qu FJ. Osteopontin promotes gastric cancer progression via phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. World J Gastrointest Oncol 2023; 15(9): 1544-1555 [PMID: 37746644 DOI: 10.4251/wjgo.v15.i9.1544] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i9/1544.htm |
| Number | Citing Articles |
| 1 |
Debarpan Chatterjee, Srijan Bhattacharya, Leena Kumari, Aparna Datta. Aptamers: ushering in new hopes in targeted glioblastoma therapy. Journal of Drug Targeting 2024; 32(9): 1005 doi: 10.1080/1061186X.2024.2373306
|
| 2 |
Hui Nian, Yu Bai, Hong-Yang Wang, Hua Yu, Zhi-Long Zhang, Ru-Hong Shi, Shu Zhang, Yi-Bin Wu, De-Hua Zhou, Qian-Cheng Du. Targeting the Osteopontin-regulated PI3K/AKT signaling pathway: A molecular approach to overcome drug resistance and metastasis in gastrointestinal tumors. World Journal of Gastrointestinal Oncology 2025; 17(11): 109923 doi: 10.4251/wjgo.v17.i11.109923
|
| 3 |
Venketesh K. Panda, Barnalee Mishra, Angitha N. Nath, Ramesh Butti, Amit Singh Yadav, Diksha Malhotra, Sinjan Khanra, Samikshya Mahapatra, Priyanka Mishra, Biswajit Swain, Sambhunath Majhi, Kavita Kumari, N. N. V. Radharani, Gopal C. Kundu. Osteopontin: A Key Multifaceted Regulator in Tumor Progression and Immunomodulation. Biomedicines 2024; 12(7): 1527 doi: 10.3390/biomedicines12071527
|
